Bone marrow samples from eight patients with MM pre-venetoclax treatment and at the time of disease progression while on venetoclax revealed a gain in the Mcl-1 mRNA transcript and downregulation of Bcl-2 at the time of relapse using single-cell RNA profiling. Here, MCL1 is linked to Miyoshi myopathy.